Phase 3Completed

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications

Sponsor
AstraZeneca (Industry)
Enrollment
261 enrolled
Conditions
Type 2 Diabetes
Interventions
placebo; exenatide
Ages
adults, older adults
Registry
NCT00765817

Full record on ClinicalTrials.gov

From the registry

This study will compare the efficacy and safety of exenatide versus placebo in adults whose diabetes is not fully controlled by insulin glargine with or without metformin and/or pioglitazone.

Primary outcomes

  • Change in Glycosylated Hemoglobin (HbA1c)

History

  1. Last registry update

  2. Results first posted

  3. Primary completion

  4. Started

  5. Registered